Abiomed, Inc. (ABMD) reported preliminary results for the third quarter of fiscal 2010. Total revenues were roughly $22.8 million, an increase of 32% year over year and were at a record high. The company will report full results for the third quarter on Feb 4, 2010.

Worldwide Impella revenues increased 81% year over year to $15.9 million. U.S. Impella revenues constituted approximately 91% of total worldwide Impella revenues and increased 116% year over year. Non-Impella revenues declined 18% year over year to $6.9 million.

Cash burn for the reported quarter was lower at $0.6 million, compared to $2.5 million in the year-ago quarter. Cash, cash equivalents, short and long-term marketable securities totaled $51.7 million, compared to $52.3 million at the end of the previous quarter.

Abiomed reported that roughly 425 U.S. commercial patients were treated with its Impella 2.5, Impella 5.0 or LD products in the third quarter, compared to 160 commercial patients in the year-ago quarter. This indicates an increasing demand for Abiomed’s products. The company has already upgraded roughly 80% of its U.S. Impella customers to its new Impella platform that included the Quick Set Up kit and software in the third quarter.

Abiomed is engaged in developing, manufacturing and marketing medical products designed to assist or replace the pumping function of a failing heart. The company’s strategy focuses on heart recovery as the goal for all acute cardiac attacks. Abiomed’s products are designed to enable the heart to rest, heal and recover.

Presently, we have a ‘Neutral’ recommendation on Abiomed stock.

Zacks Investment Research

1. (TSON) TranS1 Reports Preliminary RevenuesTranS1 Inc. (TSON) has reported preliminary revenues for the fourth quarter of 2009. Revenues are...
2. (BDX) Becton, Dickinson and Co Reports Strong ResultsBecton, Dickinson and Co. (BDX) reported strong fourth quarter and full fiscal 2009 results. For...
3. (ABMD) Abiomed, Inc’s Loss Narrower than ExpectedAbiomed, Inc. (ABMD) reported fiscal second-quarter loss of 14 cents per share, considerably better than...
4. (TLAB) Tellabs Reports Mixed Earnings ResultsTellabs Inc. (TLAB) declared its third quarter results today. Total revenues of $389.3 million were...
5. (SONC) Sonic Corporation Declares Preliminary ResultsSonic Corporation (SONC), which operates and franchises a chain of quick-service drive-in restaurants, recently declared...
6. (MDT) Positive Drug Trial Results for MedtronicMedtronic, Inc. (MDT) announced positive results from its REVERSE trial, which was designed to evaluate...

Search Posts by Tag: Abiomed Inc | ABMD | Healthcare

RSS Feeds by Tag: Abiomed Inc | ABMD | Healthcare |

Other Posts by: vitalstocks | RSS Feed for this author